GB9019611D0 - The use of macrolide compounds for cytomegalovirus infection - Google Patents

The use of macrolide compounds for cytomegalovirus infection

Info

Publication number
GB9019611D0
GB9019611D0 GB909019611A GB9019611A GB9019611D0 GB 9019611 D0 GB9019611 D0 GB 9019611D0 GB 909019611 A GB909019611 A GB 909019611A GB 9019611 A GB9019611 A GB 9019611A GB 9019611 D0 GB9019611 D0 GB 9019611D0
Authority
GB
United Kingdom
Prior art keywords
cytomegalovirus infection
macrolide compounds
macrolide
compounds
cytomegalovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB909019611A
Other versions
GB2247620A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to GB9019611A priority Critical patent/GB2247620A/en
Publication of GB9019611D0 publication Critical patent/GB9019611D0/en
Publication of GB2247620A publication Critical patent/GB2247620A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9019611A 1990-09-07 1990-09-07 The use of macrolide compounds for cytomegalovirus infection Withdrawn GB2247620A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9019611A GB2247620A (en) 1990-09-07 1990-09-07 The use of macrolide compounds for cytomegalovirus infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9019611A GB2247620A (en) 1990-09-07 1990-09-07 The use of macrolide compounds for cytomegalovirus infection

Publications (2)

Publication Number Publication Date
GB9019611D0 true GB9019611D0 (en) 1990-10-24
GB2247620A GB2247620A (en) 1992-03-11

Family

ID=10681857

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9019611A Withdrawn GB2247620A (en) 1990-09-07 1990-09-07 The use of macrolide compounds for cytomegalovirus infection

Country Status (1)

Country Link
GB (1) GB2247620A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250678A (en) 1991-05-13 1993-10-05 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
ZA926812B (en) 1991-09-09 1993-04-28 Merck & Co Inc O-heteroaryl,o-alkylheteroaryl,o-alkenylheteroaryl and o-alkynylheteroaryl macrolides having immunosupressive activity
CH686761A5 (en) * 1993-05-27 1996-06-28 Sandoz Ag Pharmaceutical formulations.
AT408520B (en) * 1993-05-27 2001-12-27 Novartis Erfind Verwalt Gmbh Pharmaceutical formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
EP0346427B1 (en) * 1987-12-09 1995-03-29 FISONS plc Macrocyclic compounds

Also Published As

Publication number Publication date
GB2247620A (en) 1992-03-11

Similar Documents

Publication Publication Date Title
AP9100313A0 (en) Compounds
GB9001245D0 (en) Compounds
AP9100314A0 (en) Compounds
GB9009469D0 (en) Compounds
GB9010221D0 (en) N-glycidyl compounds
GB9007965D0 (en) Compounds
GB9019611D0 (en) The use of macrolide compounds for cytomegalovirus infection
GB9007967D0 (en) Compounds
GB9002834D0 (en) Compounds
GB9025068D0 (en) Lactone compounds
GB9007738D0 (en) Compounds
GB9005470D0 (en) Antibiotic compounds
GB9005469D0 (en) Antibiotic compounds
GB9005465D0 (en) Antibiotic compounds
GB9012952D0 (en) New use of macrolide compounds for adiposis
GB9023989D0 (en) New use of macrolide derivative
IE901149L (en) Purpurphycin for vaginal infections
ZA916466B (en) Macrocyclic compounds
GB9017437D0 (en) Contraceptive compounds
GB9005671D0 (en) Compounds
GB9001158D0 (en) Compounds
GB9005673D0 (en) Compounds
GB9005672D0 (en) Compounds
GB9006103D0 (en) Compounds
GB9004396D0 (en) Compounds

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)